Compliance Corner: When Is An Action Exempt From FDA's Recall Reporting Requirements?
Two longtime industry experts break down the US FDA’s rules around when an action becomes reportable as a recall to the agency. The bottom line: If you’re changing a device’s safety, then you should probably report it.
You may also be interested in...
The warning letter alleges the company sold modified versions of its blood lead tests without alerting US FDA, and didn’t tell the agency about reported discrepancies in test results. FDA first warned of possible faulty test results in May.
Despite pushback from industry groups on the use of information-sharing and analysis organizations (ISAOs), US FDA has kept the language the same in its final post-market cybersecurity guidance, but has removed the term "essential clinical performance."
The US Food and Drug Administration does not expect medtech companies to submit "corrections and removals" reports for medical device enhancements that do not qualify as recalls, according to a newly finalized version of a draft guidance that came under fire by industry last year1,2.